|
1
|
Qiao J, Wang ZB, Feng HL, Miao YL, Wang Q,
Yu Y, et al: The root of reduced fertility in aged women and
possible therapentic options: Current status and future perspects.
Mol Aspects Med. 38:54–85. 2014. View Article : Google Scholar
|
|
2
|
Gizzo S, Andrisani A, Esposito F, Oliva A,
Zicchina C, Capuzzo D, et al: Ovarian reserve test: An impartial
means to resolve the mismatch between chronological and biological
age in the assessment of female reproductive chances. Reprod Sci.
21:632–639. 2014. View Article : Google Scholar
|
|
3
|
Ferraretti AP, La Marca A, Fauser BC,
Tarlatzis B, Nargund G and Gianaroli L: ESHRE working group on poor
ovarian response definition. ESHRE consensus on the definition of
'poor response' to ovarian stimulation for in vitro fertilization:
the Bologna criteria. Hum Reprod. 26:1616–1624. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patrelli TS, Gizzo S, Sianesi N, Levati L,
Pezzuto A, Ferrari B, et al: Anti-Müllerian hormone serum values
and ovarian reserve: can it predict a decrease in fertility after
ovarian stimulation by ART cycles? PLoS One. 7:e445712012.
View Article : Google Scholar
|
|
5
|
Sunkara SK, Coomarasamy A, Faris R, Braude
P and Khalaf Y: Long gonadotropin-releasing hormone agonist vs.
short agonist vs. antagonist regimens in poor responders undergoing
in vitro fertilization: a randomized controlled trial. Fertil
Steril. 101:147–153. 2014. View Article : Google Scholar
|
|
6
|
IVF Worldwide Survey: Poor responders: how
to define, diagnose and treat? Downloadable at: http://www.IVF-Worldwide.com.
(Accessed: 24/02/2014).
|
|
7
|
Shimada M, Hernandez-Gonzalez I,
Gonzalez-Robayna I and Richards JS: Paracrine and autocrine
regulation of epidermal growth factor-like factors in cumulus
oocyte complexes and granulosa cells: key roles for prostaglandin
synthase 2 and progesterone receptor. Mol Endocrinol. 20:1352–1365.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alviggi C, Clarizia R, Mollo A, Ranieri A
and De Placido G: Who needs LH in ovarian stimulation? Reprod
Biomed Online. 22(Suppl 1): 33–41. 2011. View Article : Google Scholar
|
|
9
|
Patrelli TS, Berretta R, Gizzo S, Pezzuto
A, Franchi L, Lukanovic A, et al: CA 125 serum values in surgically
treated endometriosis patients and its relationships with anatomic
sites of endometriosis and pregnancy rate. Fertil Steril.
95:393–396. 2011. View Article : Google Scholar
|
|
10
|
Saccardi C, Conte L, Fabris A, De Marchi
F, Borghero A, Gizzo S, et al: Hysteroscopic Enucleation in Toto of
Submucous type 2 myomas: Long-term follow-up in women affected by
Menorrhagia. J Minim Invasive Gynecol. 21:426–430. 2014. View Article : Google Scholar
|
|
11
|
Litta P, Cosmi E, Saccardi C, Esposito C,
Rui R and Ambrosini G: Outpatient operative polypectomy using a 5
mm-hysteroscope without anaesthesia and/or analgesia: advantages
and limits. Eur J Obstet Gynecol Reprod Biol. 139:210–214. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
World Health Organization: WHO Laboratory
Manual for the Examination of Human Semen and Sperm-Cervical Mucus
Interaction. Cambridge, UK: Cambridge University Press; 1999
|
|
13
|
Gizzo S, Capuzzo D, Zicchina C, Di Gangi
S, Coronella ML, Andrisani A, et al: Could empirical
low-dose-aspirin administration during IVF cycle affect both the
oocytes and embryos quality via COX 1 2 activity inhibition? J
Assist Reprod Genet. 31:261–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gizzo S, Patrelli TS, Rossanese M, Noventa
M, Berretta R, Di Gangi S, et al: An update on diabetic women
obstetrical outcomes linked to preconception and pregnancy glycemic
profile: a systematic literature review. Scientific World Journal.
2013:2549012013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saccardi C, Gizzo S, Ludwig K, Guido M,
Scarton M, Gangemi M, et al: Endometrial polyps in women affected
by levothyroxine-treated hypothyroidism-histological features,
immunohistochemical findings and possible explanation of
etiopathogenic mechanism: a pilot study. Biomed Res Int.
2013:5034192013. View Article : Google Scholar
|
|
16
|
Gizzo S, Andrisani A, Esposito F, Noventa
M, Di Gangi S, Angioni S, et al: Which luteal phase support is
better for each IVF stimulation protocol to achieve the highest
pregnancy rate? A superiority randomized clinical trial. Gynecol
Endocrinol. 30:1–7. 2014. View Article : Google Scholar
|
|
17
|
Son WY, Chung JT, Henderson S, Reinblatt
S, Buckett W, Chan PT, et al: Fertilization and embryo development
with spermatozoa obtained from testicular sperm extraction into
oocytes generated from human chorionic gonadotropin-primed in vitro
maturation cycles. Fertil Steril. 100:989–993. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khoudja R, Li T, Ding C, Xu Y, Liu Y, Zhou
W and Zhou C: Effect of co-incubation of oocytes with a decreasing
number of spermatozoa on embryo quality. Reprod Biomed Online.
26:353–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mochtar MH, Veen Van der, Ziech M and van
Wely M: Recombinant luteinizing hormone (rLH) for controlled
ovarian hyperstimulation in assisted reproductive cycles. Cochrane
Database Syst Rev. 18:CD0050702007.
|
|
20
|
De Placido G, Mollo A, Clarizia R, Strina
I, Conforti S and Alviggi C: Gonadotropin-releasing hormone (GnRH)
antagonist plus recombinant luteinizing hormone vs. a standard GnRH
agonist short protocol in patients at risk for poor ovarian
response. Fertil Steril. 85:247–250. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bosch E, Labarta E, Crespo J, Simón C,
Remohí J and Pellicer A: Impact of luteinizing hormone
administration on gonadotropin-releasing hormone antagonist cycles:
an age-adjusted analysis. Fertil Steril. 95:1031–1036. 2011.
View Article : Google Scholar
|
|
22
|
König TE, van der Houwen LE, Overbeek A,
Hendriks ML, Beutler-Beemsterboer SN, Kuchenbecker WK, et al:
Recombinant LH supplementation to a standard GnRH antagonist
protocol in women of 35 years or older undergoing IVF/ICSI: a
randomized controlled multicentre study. Hum Reprod. 28:2804–2812.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Filicori M, Cognigni GE, Pocognoli P,
Ciampaglia W and Bernardi S: Current concepts and novel
applications of LH activity in ovarian stimulation. Trends
Endocrinol Metab. 14:267–273. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Willis DS, Watson H, Mason HD, Galea R,
Brincat M and Franks S: Premature response to luteinizing hormone
of granulosa cells from anovulatory women with polycystic ovary
syndrome: relevance to mechanism of anovulation. J Clin Endocrinol
Metab. 83:3984–3991. 1998.PubMed/NCBI
|
|
25
|
Filicori M, Cognigni GE and Ciampaglia W:
What clinical evidence for an LH ceiling? Hum Reprod. 18:1556–1557.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gizzo S, Andrisani A, Noventa M, Quaranta
M, Esposito F, Armanini D, et al: Menstrual cycle length: a
surrogate measure of reproductive health capable of improving the
accuracy of biochemical/sonographical ovarian reserve test in
estimating the reproductive chances of women referred to ART.
Reprod Biol Endocrinol. 13:282015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ruvolo G, Bosco L, Pane A, Morici G,
Cittadini E and Roccheri MC: Lower apoptosis rate in human cumulus
cells after administration of recombinant luteinizing hormone to
women undergoing ovarian stimulation for in vitro fertilization
procedures. Fertil Steril. 87:542–546. 2007. View Article : Google Scholar
|
|
28
|
Barberi M, Ermini B, Morelli MB, Ermini M,
Cecconi S and Canipari R: Follicular fluid hormonal profile and
cumulus cell gene expression in controlled ovarian hyperstimulation
with recombinant FSH: effects of recombinant LH administration. J
Assist Reprod Genet. 29:1381–1391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kolibianakis EM, Albano C, Camus M,
Tournaye H, Van Steirteghem AC and Devroey P: Initiation of
gonadotropin-releasing hormone antagonist on day 1 as compared to
day 6 of stimulation: effect on hormonal levels and follicular
development in in vitro fertilization cycles. J Clin Endocrinol
Metab. 88:5632–5637. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kolibianakis EM, Albano C, Kahn J, Camus
M, Tournaye H, Van Steirteghem AC, et al: Exposure to high levels
of luteinizing hormone and estradiol in the early follicular phase
of gonadotropin-releasing hormone antagonist cycles is associated
with a reduced chance of pregnancy. Fertil Steril. 79:873–880.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kolibianakis E, Bourgain C, Albano C,
Osmanagaoglu K, Smitz J, Van Steirteghem A, et al: Effect of
ovarian stimulation with recombinant follicle-stimulating hormone,
gonadotropin-releasing hormone antagonists and human chorionic
gonadotropin on endometrial maturation on the day of oocyte
pick-up. Fertil Steril. 78:1025–1029. 2002. View Article : Google Scholar : PubMed/NCBI
|
